Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.

他のバージョン（1件）を表示する

BACKGROUND: Tumour necrosis factor (TNF)-alpha inhibitors are beneficial for the treatment of rheumatoid arthritis (RA) in terms of reducing the risk of joint damage, improving physical function and improving quality of life. This Cochrane review is an update of a review of the treatment of RA with...

書誌詳細
主要な著者:	Ruiz Garcia, V, Jobanputra, P, Burls, A, Cabello, J, Vela Casasempere, P, Bort-Marti, S, Kynaston-Pearson, F
フォーマット:	Journal article
言語:	English
出版事項:	2014

類似資料

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
著者:: Ruiz Garcia, V, 等
出版事項: (2011)

Certolizumab pegol in therapy for rheumatoid arthritis
著者:: Galina Viktorovna Lukina, 等
出版事項: (2012-06-01)

Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
著者:: M Connock, 等
出版事項: (2010-10-01)

QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL
著者:: Vera Nikolayevna Amirdjanova, 等
出版事項: (2012-10-01)

New aspects of the pharmacotherapy of rheumatoid arthritis: a focus on certolizumab pegol
著者:: Evgeniy L'vovich Nasonov, 等
出版事項: (2011-02-01)

Multifocal tuberculosis on certolizumab pegol in a patient followed for rheumatoid arthritis
著者:: Emna Hannech, 等
出版事項: (2021-06-01)

New treatment possibilities for rheumatoid arthritis: the Russian experience in using certolizumab pegol
著者:: Dmitry Evgenyevich Karateev, 等
出版事項: (2012-04-01)

EFFICACY OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF PSORIATIC ARTHRITIS
著者:: T. V. Korotaeva, 等
出版事項: (2015-10-01)

Certolizumab pegol – new option in the treatment of psoriatic arthritis
著者:: Maria Majdan, 等
出版事項: (2014-07-01)

Certolizumab pegol in the treatment of spondyloarthritis
著者:: Mariusz Korkosz
出版事項: (2014-09-01)

Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis
著者:: Smolen, JS, 等
出版事項: (2024)

COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM
著者:: Purcaru, O, 等
出版事項: (2010)

Prefilled certolizumab pegol (Cimzia&reg;) syringes for self-use in the treatment of rheumatoid arthritis
著者:: J Rosa, 等
出版事項: (2010-08-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS
著者:: Sh. F. Erdes
出版事項: (2016-02-01)

Eosinophilic Annular Erythema Due to Certolizumab Pegol Therapy for Rheumatoid Arthritis Post-COVID-19 Vaccine
著者:: Andrea Bassi, 等
出版事項: (2023-04-01)

The efficacy of certolizumab pegol in rheumatoid arthritis assessed by gray scale and power Doppler ultrasonography: case reports
著者:: José Alexandre Mendonça, 等
出版事項: (2019-02-01)

Exposure–Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis
著者:: Stéphane Paul, 等
出版事項: (2020-07-01)

Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
著者:: Mehmet Baysal, 等
出版事項: (2018-09-01)

Treatment of pyoderma gangrenosum in pregnancy with certolizumab pegol
著者:: Lindsey J. Wanberg, 等
出版事項: (2024-06-01)

Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials
著者:: Tanaka, Y, 等
出版事項: (2023)

Experience with long-term use of certolizumab pegol (Cimzia)
著者:: Karine Arnoldovna Lytkina, 等
出版事項: (2013-10-01)

Experience with long-term use of certolizumab pegol (Cimzia)
著者:: Karine Arnoldovna Lytkina, 等
出版事項: (2013-10-01)

A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population.
著者:: Ian R White, 等
出版事項: (2022-01-01)

A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population
著者:: Ian R. White, 等
出版事項: (2022-01-01)

Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data
著者:: Vivian P. Bykerk, 等
出版事項: (2023-02-01)

Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study
著者:: Glatt, S, 等
出版事項: (2019)

Quantitation of certolizumab pegol by validated liquid chromatography methods
著者:: Clóvis Dervil Appratto Cardoso Júnior, 等
出版事項: (2023-11-01)

Certolizumab pegol in treatment of Crohn's disease with perianal lesions
著者:: I.L. Khalif, 等
出版事項: (2018-04-01)

Active axial spondyloarthritis: potential role of certolizumab pegol
著者:: Ranatunga S, 等
出版事項: (2014-02-01)

Certolizumab pegol w leczeniu reumatoidalnego zapalenia stawów
著者:: Piotr Wiland, 等
出版事項: (2011-08-01)

An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
著者:: Acosta-Felquer ML, 等
出版事項: (2016-03-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF TAKAYASU ARTERITIS: THE FIRST EXPERIENCE AND PROSPECTS
著者:: P. I. Novikov, 等
出版事項: (2018-07-01)

Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol.
著者:: Hazes, J, 等
出版事項: (2010)

Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis
著者:: A. Spadaro, 等
出版事項: (2013-07-01)

Patient Adherence and Efficacy of Certolizumab Pegol in the Management of Crohn's Disease
著者:: Wojciech Blonski, 等
出版事項: (2012-04-01)

Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice
著者:: O V Knyazev, 等
出版事項: (2018-06-01)

Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis
著者:: Yael Sharon, 等
出版事項: (2020-06-01)

Possible relationship between certolizumab pegol and arrhythmias: report of two cases
著者:: R. Talotta, 等
出版事項: (2016-09-01)

Effectiveness of Certolizumab Pegol in Treating Rheumatoid Arthritis Patients with Persistent Inflamed Residual Mono- or Oligosynovitis Resistant to Prior TNF-α Inhibitors
著者:: Syuichi Koarada, 等
出版事項: (2015-01-01)

Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment
著者:: Jeffrey R. Curtis, 等
出版事項: (2017-12-01)